Abstract:
The Photobiomodulation Mechanism (PBM) to treat Dry Macular Degeneration and Diabetic Retinopathy disease, at the cellular level, has been attributed to the activation of components of the mitochondrial respiratory chain resulting in the stabilization of metabolic function and the initiation of a signaling cascade, which promotes cell proliferation and cytoprotection. PBM works by absorbing photons by photoreceptors in the target tissue. Once absorbed, secondary cellular effects include increases in energy production and changes in signaling modalities such as reactive oxygen species, nitric oxide, and cellular calcium. Cellular changes occur through the activation of transcription factors leading to modulation in protein synthesis, proliferation and, ultimately, better cell survival.
Audeince Take Away Notes:
- The specialized medical audience will be able to use this technique to improve thetreatment of retinal diseases, such as macular degeneration and diabetic retinopathy
- This treatment can help by understanding a new type of laser for medical treatment, inthe specialty of ophthalmology
- Without a doubt, they will be able to use this laser mechanism to continue research.
- This new therapeutic laser can solve problems in the retina, which were previouslymore difficult to solve.
- Yes, it provides new information. No problems or adverse effects have been proven so far.
Biography:
He is a Director and Vitreoretinal Consultant at Oftalmo Abad, Clínica de Ojos, Santa Cruz, Argentina, Ambassador at UNESCO for Argentina, Medical Doctor, Cordoba National University, Córdoba, Argentina, Diploma in Ophthalmology, Council Doctors of Santa Cruz, Argentina and Argentine Society of Ophthalmology, Philosophy Doctor in Genetics and Cell Biology, Bircham International University, Spain, Master of Business Administration in Medical Institutions, Bircham International University, Spain, Honorary Distinction “Magna Cum Laude”, (doctoral thesis), Bircham International University, Spain, Doctor Honoris Causa, contribution to the knowledge and to the scientific research in Ophthalmology, Bircham International University, Madrid, Spain, Philosophy Doctor as researcher, International Philosophical Institute, India, Doctor of Sciences in Ophthalmology “ad eundem” (education and practice in Ophthalmology) Ballsbridge University, Roseau, Commonwealth of Dominica, Doctor of Sciences as Boitech researcher, Research Training & Treatment Institute, Jodhpur, India, "American Grand President Sir", International Chartered World Learned Society, Chancellor for Education, Peace and Justice, Nigeria, Doctor of Letters in Medical Research, Maha Sastra University, Sastra Angkor Institute, The Kingdom of Cambodia, Associate Fellow at New York Academy of Medicine, NY, USA, Golden Medal of Excellence “International Health Professional of the Year -2012” (scientifics research), International Biographical Centre, Cambridge, England, International Award, Marquis Who’s Who in America (scientific publications), New York, USA, Honorary Fellow, Institute the Chartered Professionals (optics researcher), Ireland, UK, Honourable Global Member Council of the Board of Quality Standards, Ireland, UK, Board of Research Advisor at Sastra Angkor University, The Kingdom of Cambodia, Academic Representative in Argentina and worldwide, California University FCE, California, USA, President, International Research Group, Abad Eye Research, Ballsbridge University, Distinguished University Professor and Dean of Ophthalmology at Ballsbridge University, Roseau, Dominica and Republic of Ghana , Dean of Medicine and Distinguished Professor of Ophthalmology at West Coast University, USA, Americas Rector at Crown University, Africa, Creator of devises and systems for ophthalmic surgery and intraocular micro-implant for degenerative diseases of the retina /International Patents in Europe and USA, Published more than eighty articles in scientific journals, Author of thirteen books of Ophthalmology
